Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Original Research

1. Epigallocatechin-3-Gallate Protects Erythrocyte Ca2+-ATPase and Na+/K+-ATPase Against Oxidative Induced Damage During Aging in Humans

Prabhanshu Kumar, Pawan Kumar Maurya*

Adv Pharm Bull. 2014;4(5): 443-447. doi: 10.5681/apb.2014.065

PMCID: PMC4213783 PMID: 25364660 Scopus ID: 84906727809

Article

PDF

XML

Cited By:

23

9

Review Article

2. Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease

Suggala Ramya Shri , Suman Manandhar , Yogendra Nayak , K Sreedhara Ranganath Pai*

Adv Pharm Bull. 2023;13(4): 688-700. doi: 10.34172/apb.2023.071

PMCID: PMC10676556 PMID: 38022801

Article

PDF

Full Text

XML

Cited By:

11

Review Article

3. Purinergic Receptor (P2X7R): A Promising Anti-Parkinson’s Drug Target

Saivarshini Magham , M. Lalith Kumar, Praveen Thaggikuppe Krishnamurthy* , Neenu Shaji, Aishwarya Reddy Ramakkamma

Adv Pharm Bull. 2024;14(4): 807-818. doi: 10.34172/apb.43206

Article

PDF

XML

Cited By: